Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The main objective of this study is to assess safety and tolerability of Intradermal (ID) BOTOX in participants with facial fine lines.
Description: Unique number of participants who experience one or more treatment emergent adverse event
Measure: Number of Participants with Adverse Events (AEs) Time: Baseline (Day 1) to Final Visit (up to Day 97)Description: Unique number of participants who experience one or more Potential Clinically Significant (PCS) change in vital signs from the Baseline visit.
Measure: Number of Participants with Potential Clinically Significant (PCS) changes in vital signs Time: Baseline (Day 1) to Final Visit (up to Day 97)Description: Unique number of participants who experience one or more Potential Clinically Significant (PCS) change in physical exams from the Baseline visit.
Measure: Number of Participants with Potential Clinically Significant (PCS) changes in physical exams Time: Baseline (Day 1) to Final Visit (up to Day 97)Description: Unique number of participants who experience injection site pain and/or discomfort at the injection site during administration of treatment.
Measure: Number of Participants with injection site pain/discomfort. Time: Baseline (Day 1)Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports